Center Ventures

Center Ventures

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Taiwan, Taipei

About

The VC's location is in Asia, Taiwan. The main office of this VC is situated in Taipei.

The fund typically enters into less than 2 deals annually. Typical investments for this fund are deals in the range of more than 100 millions dollars. The fund's activity peaked in 2018. The highest number of exits from this fund were in 2019.

The fund typically invests in rounds with 8 participants. Besides Center Ventures, start-ups are typically funded by Chengwei Capital. The fund often co-invests with Yuanta Financial Holdings Group, Vivo Capital, GoldTech.

The average start-up age at the time of investment by this fund is 6-10. TOT BIOPHARM is amongst the various portfolio company of this fund. The country of its establishment and the country of its most frequent investments doesn't coincide - China. Among the most popular investment industries for the fund are Medical, Pharmaceutical. However, the fund’s focus is not limited to this, since there is 1 more area of investment.

Fund Activity

Operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: venturecenter.co; User name format in descending order of probability: first, first '.' last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Funds Investing in Previous
Rounds

Chengwei Capital

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: